Reply to: “Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything” and “More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations”

Lauren A. Beste; Pamela K. Green; Kristin Berry; Matthew J. Kogut; Stephen K. Allison; George N. Ioannou

首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Reply to: “Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything” and “More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations”

【24h】

Reply to: “Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything” and “More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations”

机译：回复：“肝细胞癌患者的直接作用抗病毒治疗：治疗的时机是一切”和“患有HCC患者的DAA治疗患者的一切”和更扩展的患者指示“

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Hepatology: The Journal of the European Association for the Study of the Liver》 |2018年第1期|共2页
作者
Lauren A. Beste; Pamela K. Green; Kristin Berry; Matthew J. Kogut; Stephen K. Allison; George N. Ioannou;
展开▼
作者单位

General Medicine Service Veterans Affairs Puget Sound Health Care System;

Health Services Research and Development Veterans Affairs Puget Sound Health Care System;

Health Services Research and Development Veterans Affairs Puget Sound Health Care System;

Diagnostic Imaging Service Veterans Affairs Puget Sound Health Care System;

Diagnostic Imaging Service Veterans Affairs Puget Sound Health Care System;

Health Services Research and Development Veterans Affairs Puget Sound Health Care System;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to: “Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything” and “More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations” [J] . Lauren A. Beste, Pamela K. Green, Kristin Berry, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018,第1期

机译：回复：“肝细胞癌患者的直接作用抗病毒治疗：治疗的时机是一切”和“患有HCC患者的DAA治疗患者的一切”和更扩展的患者指示“
2. More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations [J] . Devi Tammineedi, Jacob Eisert, Johnson Ukken, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018,第1期

机译：在HCC，负担能力和进一步的统计考虑患者中更扩展DAA治疗的指示
3. Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything [J] . Chiara Mazzarelli, Mary D. Cannon, Luca S. Belli, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018,第1期

机译：肝细胞癌患者的直接作用抗病毒药疗法：治疗时间是一切
4. Fewer Somatic Mutations of Mitochondrial Dna in Noncancerous Liver Tissue of Patients With Hepatocellular Carcinoma Respond To interferon therapy [C] . Shuhei Nishiguchi, Manabk Nishikawa, Masayasu inoue, Yamaguchi Symposium on Liver Disease . 2003

机译：肝细胞癌患者的非癌症肝组织中的线粒体DNA的细胞突变较少，对干扰素治疗反应
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease [O] . Charles De Comarmond, Hendren Bajillan, Bailey Guest 2017

机译：直接作用（DAA）治疗丙型肝炎病毒（HCV）对晚期肝病患者肝细胞癌（HCC）发病率的影响
7. Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group [O] . Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, 2018

机译：在治疗肝细胞癌后，是否对丙型肝炎进行丙型肝炎的干扰素直接抗病毒治疗导致HCC的意外复发？日本红十字医院肝脏研究组的多中心研究

Reply to: “Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything” and “More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations”

著录项

相似文献

相关主题

期刊订阅